Intellipharmaceutics International Inc. (IPCIF)

IPCIF Cash Flow Statement

Financials in millions USD. Fiscal year is December - November.

Year	2022	2021	2020	2019	2018
Net Income	-2.89	-2.89	-5.15	-3.39	-13.74
Depreciation & Amortization	0.21	0.21	0.26	0.42	0.61
Share-Based Compensation	0	0.01	0.07	0.26	0
Other Operating Activities	1.3	1.29	2.35	2.82	0.62
Operating Cash Flow	-1.39	-1.39	-2.46	0.11	-12.51
Capital Expenditures	0	0	-0	-0	-0.1
Acquisitions	0.48	0	0.03	0	0
Other Investing Activities	0.02	0.5	-0	0.03	-
Investing Cash Flow	0.5	0.5	0.03	0.03	-0.1
Common Stock Issued	0	3.07	3.07	0.03	19.64
Other Financing Activities	0.2	-2.87	-0.04	0.07	-2.29
Financing Cash Flow	0.2	0.2	3.03	0.1	17.35
Net Cash Flow	-0.69	-0.69	0.57	0.14	4.74
Free Cash Flow	-1.39	-1.39	-2.47	0.11	-12.61
Free Cash Flow Margin	-2112.07%	-2112.07%	-175.90%	7.72%	-736.26%
Free Cash Flow Per Share	-0.04	-0.05	-0.10	0.01	-2.65

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.